Lucid Diagnostics (LUCD) Revenue (2021 - 2026)
Lucid Diagnostics (LUCD) posted Revenue of $1.3 million for Q1 2026, down 13.22% on a QoQ basis from $1.5 million in Q4 2025, and up 57.0% year-over-year from $828000.0 in Q1 2025.
Lucid Diagnostics (LUCD) Revenue (2021 - 2026) Analysis & Trends
Lucid Diagnostics' Revenue history runs 6 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- Quarterly Revenue rose 57.0% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (up 24.83% YoY) and the FY2025 annual result came in at $4.7 million, up 8.15% from the prior year.
- Revenue was $1.3 million for Q1 2026 at Lucid Diagnostics, down from $1.5 million in the prior quarter.
- Across five years, Revenue topped out at $1.5 million in Q4 2025 and bottomed at $76000.0 in Q3 2022.
- A 5-year average of $824250.0 and a median of $988500.0 in 2024 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue plunged 62.67% — and 2023, when it surged 930.26%.
- Lucid Diagnostics' Revenue stood at $112000.0 in 2022, then jumped by 828.57% to $1.0 million in 2023, then climbed by 15.1% to $1.2 million in 2024, then climbed by 25.15% to $1.5 million in 2025, then slipped by 13.22% to $1.3 million in 2026.
- Business Quant data shows LUCD's Revenue at $1.3 million in Q1 2026, $1.5 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 11.16 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.02 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 9.81 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 5.20 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.65 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.19 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.57 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 828,000.00 |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 976,000.00 |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 783,000.00 |
| Jun 30, 2023 | 159,000.00 |
| Mar 31, 2023 | 446,000.00 |
| Dec 31, 2022 | 112,000.00 |
| Sep 30, 2022 | 76,000.00 |
| Mar 31, 2022 | 189,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 200,000.00 |